Duchenne Muscular Dystrophy Market to Reach $2.1 Billion, Globally, by 2031 at 4.7% CAGR: Allied Market Research

Rise in the incidence of the Duchenne muscular dystrophy (DMD) and surge in need for better healthcare services drive the growth of the global Duchenne muscular dystrophy market.

PORTLAND, Ore., Nov. 28, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Duchenne Muscular Dystrophy Market by Therapeutic Area, (Molecular-based Therapies and Steroid Therapy), and Distribution Channel (Hospital Pharmacies, Drug Store & Retail Pharmacies and Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2022-2031". According to the report, the global Duchenne muscular dystrophy industry generated $1.3 billion in 2021, and is anticipated to generate $2.1 billion by 2031, witnessing a CAGR of 4.7% from 2022 to 2031.

Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/16015

Prime determinants of growth

Rise in the incidence of the Duchenne muscular dystrophy (DMD) and surge in need for better healthcare services drive the growth of the global Duchenne muscular dystrophy market. However, inflated cost of treatments for Duchenne muscular dystrophy restricts the market growth. On the other hand, increase in government spending on the pharmaceutical and biotechnology sectors in developing countries, the development of healthcare infrastructure, and rise in demand for innovative treatments for Duchenne muscular dystrophy present new opportunities in the coming years.

Covid-19 Scenario

• The outbreak of the Covid-19 pandemic had a negative impact on the global Duchenne muscular dystrophy market, owing to implementation of the global lockdown which led to temporary closure of many clinics, especially in the initial period.
• However, throughout the pandemic, despite the recommendations to maintain social distance, many individuals treated their illnesses via self-medication or other unconventional methods owing to their concern of contracting COVID during the lockdown.

The molecular based therapies segment to maintain its leadership status throughout the forecast period

Based on therapeutic area, the molecular based therapies segment held the highest market share in 2021, accounting for around three-fifths of the global Duchenne muscular dystrophy market, and is estimated to maintain its leadership status throughout the forecast period. In addition, the same segment is projected to manifest the highest CAGR of 5.0% from 2022 to 2031, owing to R & D activities for exon skipping drugs, strong product pipeline and significant product launch by key players. The report also discusses steroid therapy segment.

Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/16015

The hospital pharmacies segment to maintain its lead position during the forecast period

Based on distribution channel, the hospital pharmacies segment accounted for the largest share in 2021, contributing to more than three-fifths of the global Duchenne muscular dystrophy market, and is projected to maintain its lead position during the forecast period. This is owing to significant rise in the number of diagnosis through hospitals. However, the drug store & retail pharmacies segment is expected to portray the largest CAGR of 5.4% from 2022 to 2031, owing to the rise in the approval of drugs and their availability in drug store & retail pharmacies.

North America to maintain its dominance by 2031

Based on region, North America held the highest market share in terms of revenue in 2021, accounting for more than half of the global Duchenne muscular dystrophy market, and is likely to dominate the market during the forecast period. This is owing to technological advancements in Duchenne muscular dystrophy treatment and presence of key players & robust hospital infrastructure in the region. However, the Asia-Pacific region is expected to witness the fastest CAGR of 5.9% from 2022 to 2031. This is owing to rise in cases of Duchenne muscular dystrophy, approval of drugs, development of healthcare infrastructure, and increase in investments projects in the region.

Leading Market Players: -

• F Hoffmann-La Roche AG
• FibroGen, Inc
• GlaxoSmithKline plc
• Italfarmaco S.p.A.
• Nippon Shinyaku Co., Ltd
• Pfizer Inc.
• PTC Therapeutics
• Santhera Pharmaceuticals Inc
• Sarepta therapeutics
• Wave life sciences ltd.

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Fall Management Market by Product (Sensor Pad, Floor Mat and RFID Tag): Global Opportunity Analysis and Industry Forecast, 2020-2030

Enteral Nutrition Market by Protein Composition (Standard Protein Diet, High Protein Supplement, Protein for Diabetes Care Patient and Others), Form (Powder and Liquid), Age Group (Adults, and Pediatric), and Distribution Channel (Hospital Sales, Retail, and Online): Global Opportunity Analysis and Industry Forecast, 2020-2030

Surgical Robotics Market by Component (Systems, Accessories and Services), by Surgery Type (Gynecology Surgery, Urology Surgery, Neurosurgery, Orthopedic Surgery, General Surgery and Other Surgeries): Global Opportunity Analysis and Industry Forecast, 2020-2030

Surgical Drains Market by Product (Open surgical drainage system, Closed surgical drainage system), by Application (General Surgery, Cardiac & Thoracic Surgery, Orthopedic Surgery, Obstetric/Gynecological Surgery, Other Surgeries), by Type (Active Drains, Passive Drains), by End User (Hospitals, Ambulatory surgery centers (ASCs) & clinics): Global Opportunity Analysis and Industry Forecast, 2020-2030

Over The Counter (OTC) Test Market by Product Type (Glucose Monitoring Test, Pregnancy & Fertility test, Coagulation Monitoring Test, Urinalysis Test, Cholesterol Test, and Other Test), Technology (Lateral Flow Assays, Immunoassays, and Dipsticks), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2021-2030

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg